Tris(2-methyl-1-aziridinyl)phosphine oxide

Modify Date: 2024-01-02 22:08:22

Tris(2-methyl-1-aziridinyl)phosphine oxide Structure
Tris(2-methyl-1-aziridinyl)phosphine oxide structure
Common Name Tris(2-methyl-1-aziridinyl)phosphine oxide
CAS Number 57-39-6 Molecular Weight 215.23200
Density 1.27 g/cm3 Boiling Point 90-92 °C (0.15-0.3 mmHg)
Molecular Formula C9H18N3OP Melting Point 25℃
MSDS N/A Flash Point 142.3ºC

 Names

Name metepa
Synonym More Synonyms

 Chemical & Physical Properties

Density 1.27 g/cm3
Boiling Point 90-92 °C (0.15-0.3 mmHg)
Melting Point 25℃
Molecular Formula C9H18N3OP
Molecular Weight 215.23200
Flash Point 142.3ºC
Exact Mass 215.11900
PSA 35.91000
LogP 1.02050
Index of Refraction n20/D 1.579(lit.)

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
SZ1925000
CHEMICAL NAME :
Phosphine oxide, tris(2-methyl-1-aziridinyl)-
CAS REGISTRY NUMBER :
57-39-6
LAST UPDATED :
199701
DATA ITEMS CITED :
56
MOLECULAR FORMULA :
C9-H18-N3-O-P
MOLECULAR WEIGHT :
215.27
WISWESSER LINE NOTATION :
T3NTJ B1 APO&- AT3NTJ B1&- AT3NTJ B1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
136 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
183 mg/kg
TOXIC EFFECTS :
Behavioral - food intake (animal) Gastrointestinal - hypermotility, diarrhea Lungs, Thorax, or Respiration - dyspnea
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
292 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
375 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
3125 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
140 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Bird - chicken
DOSE/DURATION :
329 mg/kg
TOXIC EFFECTS :
Peripheral Nerve and Sensation - flaccid paralysis without anesthesia (usually neuromuscular blockage) Behavioral - ataxia
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - domestic
DOSE/DURATION :
50 mg/kg
TOXIC EFFECTS :
Behavioral - ataxia Lungs, Thorax, or Respiration - cyanosis Liver - hepatitis (hepatocellular necrosis), diffuse
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1050 mg/kg/15W-I
TOXIC EFFECTS :
Peripheral Nerve and Sensation - flaccid paralysis with appropriate anesthesia Related to Chronic Data - death Related to Chronic Data - changes in testicular weight
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
480 mg/kg/8D-I
TOXIC EFFECTS :
Blood - pigmented or nucleated red blood cells Blood - changes in erythrocyte (RBC) count Blood - changes in leukocyte (WBC) count
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
840 mg/kg/84D-I
TOXIC EFFECTS :
Nutritional and Gross Metabolic - weight loss or decreased weight gain Related to Chronic Data - death Related to Chronic Data - changes in testicular weight
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1000 mg/kg/60W-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Brain and Coverings - tumors Blood - leukemia
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
200 ug/kg
SEX/DURATION :
female 1 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Effects on Newborn - weaning or lactation index (e.g., # alive at weaning per # alive at day 4)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
140 mg/kg
SEX/DURATION :
male
TOXIC EFFECTS :
Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth) Reproductive - Fertility - other measures of fertility Reproductive - Effects on Newborn - live birth index (measured after birth)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
193 mg/kg
SEX/DURATION :
male 77 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - testes, epididymis, sperm duct
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
1 mg/kg
SEX/DURATION :
male 1 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Fertility - male fertility index (e.g. # males impregnating females per # males exposed to fertile nonpregnant females) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth) Reproductive - Effects on Newborn - stillbirth
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
350 mg/kg
SEX/DURATION :
male 70 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Fertility - male fertility index (e.g. # males impregnating females per # males exposed to fertile nonpregnant females)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
500 ug/kg
SEX/DURATION :
female 1 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Fertility - female fertility index (e.g. # females pregnant per # sperm positive females; # females pregnant per # females mated) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
30 mg/kg
SEX/DURATION :
female 12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
30 mg/kg
SEX/DURATION :
female 12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - extra-embryonic structures (e.g., placenta, umbilical cord)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
8750 ug/kg
SEX/DURATION :
female 7-13 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
30 mg/kg
SEX/DURATION :
female 11 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
12500 ug/kg
SEX/DURATION :
male 1 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
25 mg/kg
SEX/DURATION :
male 1 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
25 mg/kg
SEX/DURATION :
female 5 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Effects on Newborn - germ cell effects (in offspring)
TYPE OF TEST :
Sex chromosome loss and nondisjunction
TYPE OF TEST :
Dominant lethal test
TYPE OF TEST :
Mutation test systems - not otherwise specified
TYPE OF TEST :
Cytogenetic analysis
TYPE OF TEST :
Dominant lethal test
TYPE OF TEST :
Dominant lethal test
TYPE OF TEST :
Dominant lethal test
TYPE OF TEST :
Dominant lethal test
TYPE OF TEST :
Sperm Morphology
TYPE OF TEST :
Cytogenetic analysis
TYPE OF TEST :
Cytogenetic analysis
TYPE OF TEST :
Micronucleus test
TYPE OF TEST :
Dominant lethal test

MUTATION DATA

TEST SYSTEM :
Rodent - mouse
DOSE/DURATION :
30 mg/kg/5D
REFERENCE :
PNASA6 Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing & Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- Volume(issue)/page/year: 72,4425,1975 *** REVIEWS *** IARC Cancer Review:Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 9,107,1975 IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 9,107,1975 IARC Cancer Review:Group 3 IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,56,1987 TOXICOLOGY REVIEW 32XPAD "Teratology," Berry, C.L., and D.E. Poswillo, eds., New York, Springer, 1975 Volume(issue)/page/year: -,49,1975 TOXICOLOGY REVIEW 85CVA2 "Oncology 1970, Proceedings of the Tenth International Cancer Congress," Chicago, Year Book Medical Pub., 1971 Volume(issue)/page/year: 5,250,1970

 Safety Information

Hazard Codes Xi
Risk Phrases R38:Irritating to the skin.
Safety Phrases S37/39:Wear suitable gloves and eye/face protection . S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
RIDADR 2810
WGK Germany 1
Packaging Group III
Hazard Class 6.1(b)
HS Code 29310095

 Precursor & DownStream

Precursor  1

DownStream  0

 Customs

HS Code 2933990012
Summary 2933990012. VAT:17.0%. Tax rebate rate:9.0%. Supervision conditions:S(import or export registration certificate for pesticides). MFN tariff:6.5%. General tariff:20.0%

 Synonyms

Methaphoxide
METEPA
EMT 50,003
1,1’,1″-phosphoryltris(2-methylaziridine)
2,2',2''-trimethyl-1,1',1''-phosphoryl-tris-aziridine
EINECS 200-326-5
1-bis(2-methylaziridin-1-yl)phosphoryl-2-methylaziridine
Methyl aphoxide
ENT 50,003
MAPO
tris(2-methyl-1-aziridinyl)phosphine oxide
Metapoxide
1,1’,1″-phosphinylidynetris[2-methylaziridine]
Top Suppliers:I want be here


Get all suppliers and price by the below link:

Tris(2-methyl-1-aziridinyl)phosphine oxide suppliers

Tris(2-methyl-1-aziridinyl)phosphine oxide price

Related Compounds: More...
Calcium(2+), tris[tris(2-methyl-1-aziridinyl)phosphine oxide-O]-, dichloride
58429-41-7
Phosphine sulfide, tris(2-methyl-1-aziridinyl)- (8CI)
76-96-0
Phosphonic diamide, P- (2-methyl-1-aziridinyl)-N,N,N, N-tetra-2-propenyl-
58588-70-8
(1-Aziridinyl)(2-methyl-1-aziridinyl)diallylaminophosphine oxide
41657-19-6
Aziridine,1,1',1''-phosphinylidynetris[2,2-dimethyl- (9CI)
15312-14-8
Phosphine sulfide, tris (2-methyl-1-aziridinyl)-, (L)-
20662-50-4
1,3,5-Triazine,2,4,6-tris(2-methyl-1-aziridinyl)-
13009-91-1
1,3,5-Triazine,2,4,6-tris(2-methyl-1-aziridinyl)-, stereoisomer
20708-31-0
tris(2-methyl-1-propyl) phosphate radical
83561-06-2
4-methoxy-1-methyl-5-{6H,7H,8H,9H-pyrido[2,3-b]1,6-naphthyridine-7-carbonyl}-1,2-dihydropyridin-2-one
2741897-12-9
1-{2-Tert-butylimidazo[1,2-b]pyridazin-6-yl}-4-(2-cyclopropyl-6-methylpyrimidin-4-yl)-1,4-diazepane
2742015-82-1
1-ethyl-3,5-dimethyl-4-{6H,7H,8H,9H-pyrido[2,3-b]1,6-naphthyridine-7-sulfonyl}-1H-pyrazole
2742015-94-5
1-methyl-2-{6H,7H,8H,9H-pyrido[2,3-b]1,6-naphthyridine-7-sulfonyl}-1H-imidazole
2742042-27-7
4-phenyl-2-(3-{[2-(propan-2-yl)-1H-imidazol-1-yl]methyl}azetidin-1-yl)-1,3-thiazole
2742027-16-1
12-[4-(3,6-Dimethylpyrazin-2-yl)oxypiperidin-1-yl]-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene
2741923-31-7
2-(3-methoxyphenoxy)-1-{6H,7H,8H,9H-pyrido[2,3-b]1,6-naphthyridin-7-yl}ethan-1-one
2741944-32-9
2-{4-[(3,6-dimethylpyrazin-2-yl)oxy]piperidin-1-yl}-N-(prop-2-en-1-yl)acetamide
2741938-89-4
3-[({2-tert-butylimidazo[1,2-b]pyridazin-6-yl}oxy)methyl]-1-{5H,6H,7H-cyclopenta[d]pyrimidin-4-yl}pyrrolidine
2742062-68-4
N-[2-(4-methoxyphenyl)ethyl]-N-methylpyrazolo[1,5-a]pyrazin-4-amine
2742062-91-3